Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry:: Comparison of a volumetric assay and the ISHAGE gating strategy

被引:34
作者
Leuner, S [1 ]
Arland, M [1 ]
Kahl, C [1 ]
Jentsch-Ullrich, K [1 ]
Franke, A [1 ]
Höffkes, HG [1 ]
机构
[1] Univ Magdeburg, Dept Med, Div Hematol Oncol, D-39120 Magdeburg, Germany
关键词
progenitor cells; CD34; flow cytometry; stem cell transplantation;
D O I
10.1038/sj.bmt.1701397
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In order to optimize peripheral blood stem cell (PBSC) collection for transplantation, absolute CD34 counts are necessary to determine the exact time-point for sufficient leukapheresis. In an effort to establish and to validate a rapid and reproducible assay for PBSC enumeration, different recommendations for selection of monoclonal antibodies, lysis techniques, analysis parameters and gating strategies were developed. In this methodical study, two gating strategies for PBSC enumeration were compared, in order to validate the accuracy of PBSC counting in peripheral blood and apheresis products, Gating strategy I was performed using volumetric how cytometry and reference beads whereas gating strategy II was done according to the ISHAGE guidelines. The highly standardized volumetric assay seems to be superior to the more 'expert-reliant' ISHAGE procedure requiring more 'manual work' by the cytometrist.
引用
收藏
页码:699 / 706
页数:8
相关论文
共 25 条
[1]   Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma [J].
Barlogie, B ;
Jagannath, S ;
Vesole, DH ;
Naucke, S ;
Cheson, B ;
Mattox, S ;
Bracy, D ;
Salmon, S ;
Jacobson, J ;
Crowley, J ;
Tricot, G .
BLOOD, 1997, 89 (03) :789-793
[2]  
BENDER JG, 1994, BONE MARROW TRANSPL, V13, P479
[3]  
BENDER JG, 1991, BLOOD, V77, P2591
[4]  
Brecher M E, 1996, J Hematother, V5, P227, DOI 10.1089/scd.1.1996.5.227
[5]  
Chin-Yee I., 1997, Clin. Immunol. Newsl, V17, P21, DOI [10.1016/S0197-1859(97)81348-9, DOI 10.1016/S0197-1859(97)81348-9]
[6]   PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COUNTS DURING STEADY-STATE HEMATOPOIESIS ALLOW TO ESTIMATE THE YIELD OF MOBILIZED PBPC AFTER FILGRASTIM (R-METHUG-CSF)-SUPPORTED CYTOTOXIC CHEMOTHERAPY [J].
FRUEHAUF, S ;
HAAS, R ;
CONRADT, C ;
MUREA, S ;
WITT, B ;
MOHLE, R ;
HUNSTEIN, W .
BLOOD, 1995, 85 (09) :2619-2626
[7]  
HOHAUS S, 1993, EXP HEMATOL, V21, P508
[8]   THE IMPORTANCE OF DOSE INTENSITY IN CHEMOTHERAPY OF METASTATIC BREAST-CANCER [J].
HRYNIUK, W ;
BUSH, H .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (11) :1281-1288
[9]  
Johnsen H E, 1995, J Hematother, V4, P21, DOI 10.1089/scd.1.1995.4.21
[10]  
Johnsen H E, 1996, J Hematother, V5, P237, DOI 10.1089/scd.1.1996.5.237